Drug Approval | August 16, 2023
Eugia Pharma receives USFDA Approval for Icatibant Injection
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
SÜDPACK is setting standards in terms of both performance and sustainability
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Women of all ages will get round-the-clock access to comprehensive treatment
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Subscribe To Our Newsletter & Stay Updated
